The Glaucoma Research Foundation’s mission is to cure glaucoma and restore vision through innovative science. For more than 40 years, we have funded groundbreaking laboratory and clinical research that is changing the course of glaucoma care. Our work would not be possible without the generosity and dedication of people around the world who share our deep commitment to a future free from glaucoma, for everyone.
H. Dunbar Hoskins Jr., MD, passes away at 84
February 8th 2024Hoskins was a pioneer and leader in the field of ophthalmology and glaucoma, and served as executive vice president of the American Academy of Ophthalmology, founding director and Director Emeritus of the Glaucoma Research Foundation, and a founding director of the American Glaucoma Society.
Glaucoma 360: An update on IOLs - when and how to use them
February 4th 2023Shan C. Lin, MD, provides an overview of the various intraocular lens technologies that are available, as well as considerations for contrast sensitivity and vision loss in patients at Glaucoma Research Foundation's annual Glaucoma Symposium.
Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma
February 3rd 2023Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, took the podium at the New Horizons Forum at the Glaucoma 360 conference in San Francisco to discuss the performance of the company’s episcleral venous pressure eyedrop, QLS-111.
Glaucoma 360: A bird's-eye view of innovation
February 3rd 2023Kristen H. Ingenito, MBA, vice president and director of ophthalmics at Market Scope, discusses the volume of ophthalmologists offering interventional glaucoma treatment as well as emerging therapies in her presentation at the Glaucoma 360 New Horizons Forum.
Glaucoma 360: Exploring remote monitoring of glaucoma
February 12th 2022Oluwatosin U. Smith, MD, associate professor in the Department of Ophthalmology, University of Texas Southwestern, Dallas, speaks with Ophthalmology Times'® Sheryl Stevenson on the highlights of her presentation exploring remote monitoring of glaucoma and the future of virtual care on the whole.